Rigorous research and developments on other BMP applications have become critical differentiating strategy. However, Rising Traumatic Injury Caseloads Remain Pivotal to Growth.
Players Uncovering Potential Avenues in Dentistry
The utilization of bone morphogenetic proteins is not only concentrated on osteogenic regeneration. Instead, BMP producers, along with medical researchers, are conducting extensive studies in other areas, including periodontal regeneration and tooth conservation procedures. In dentistry, BMP-2 is seeing huge demand uptick in several medical procedures, including sinus lift augmentation, alveolar bone regeneration, and dental implants. Such discoveries are influencing market players to devise innovative biomaterials for BMP delivery in these potential avenues.
BMPs to Act as Possible Bridge between Bone Metabolism with Obesity
Riding the wave of meticulous Research and Development, players in bone morphogenetic proteins market are striving to determine relationship between bone metabolism and obesity as well as glucose metabolism. Studies have highlighted impact of bone morphogenetic proteins – BMP9, BMP7, BMP6, BMP4, and BMP2 – on pathophysiological process of glucose metabolism and obesity beyond bone metabolism. Furthermore, holistic understanding of impacts of bone morphogenetic proteins could help market players better understand bone metabolism in obesity and type-2 diabetes.
The report underscores fast-paced growth of bone morphogenetic proteins market in Asia Pacific (APAC). Increasing healthcare spending, especially in
China, India, and Singapore, and rising prominence of recombinant human bone morphogenetic proteins (rhBMP) are critical growth engines.
Besides, cost-effective healthcare services, superior hospitality, and leading-edge medical technologies (MedTech) have bolstered medical tourism in APAC. Thailand, Malaysia, and India are leading the pack in this theme.
Competitive Landscape
ResearchMOZ underscores the competitive gradient of the bone morphogenetic proteins market which would enable the new entrants to extract factual information regarding the strategies adopting by the leading players in order to dive deeper into the uncharted regions and grab their positions.
The leading players of the bone morphogenetic proteins market are
- ProSpec
- DePuy Synthes
- Ember Therapeutics Inc
- Sigma-Aldrich Corporation
- R&D Systems
- Cellumed Co. Ltd
Read More: https://www.beetribune.com/bone-morphogenetic-proteins-market-overview/
